Vaxcyte, Inc. (PCVX)
NASDAQ·Healthcare·Biotechnology
$58.56
-1.69%
Mkt Cap $8.75B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 24, 2026 | $18.75M | — | — | -$1.53 | -$1.80 | -17.67% | — | — |
| Q4 2025 Nov 4, 2025 | — | — | — | -$1.27 | -$1.56 | -22.83% | — | — |
| Q3 2025 Aug 6, 2025 | — | — | — | -$1.12 | -$1.22 | -8.93% | — | — |
| Q2 2025 May 7, 2025 | — | — | — | -$1.02 | -$1.04 | -1.96% | — | — |
| Q1 2025 Feb 25, 2025 | — | — | — | -$1.16 | -$1.02 | +12.07% | — | — |
| Q4 2024 Nov 5, 2024 | — | — | — | -$1.10 | -$0.83 | +24.55% | — | — |
| Q3 2024 Aug 6, 2024 | — | — | — | -$0.98 | -$1.10 | -12.75% | — | — |
| Q2 2024 May 8, 2024 | — | — | — | -$1.13 | -$0.85 | +24.78% | — | — |
| Q1 2024 Feb 27, 2024 | — | $14.45M | — | -$0.90 | -$1.82 | -102.22% | — | — |
| Q4 2023 Nov 6, 2023 | — | — | — | -$0.79 | -$0.91 | -15.19% | — | — |
| Q3 2023 Aug 8, 2023 | — | — | — | -$0.67 | -$0.70 | -4.48% | — | — |
| Q2 2023 May 8, 2023 | — | — | — | -$0.80 | -$0.70 | +12.50% | — | — |
| Q1 2023 Feb 27, 2023 | — | — | — | -$0.84 | -$0.73 | +13.10% | — | — |
| Q4 2022 Nov 7, 2022 | — | — | — | -$0.80 | -$0.93 | -16.25% | — | — |
| Q3 2022 Aug 8, 2022 | — | — | — | -$0.69 | -$0.80 | -15.94% | — | — |
| Q2 2022 May 9, 2022 | — | — | — | -$0.56 | -$0.68 | -21.43% | — | — |
| Q1 2022 Feb 28, 2022 | — | — | — | -$0.46 | -$0.54 | -17.39% | — | — |
| Q4 2021 Nov 10, 2021 | — | — | — | -$0.47 | -$0.51 | -8.51% | — | — |
| Q3 2021 Aug 11, 2021 | — | — | — | -$0.46 | -$0.46 | +0.00% | — | — |
| Q2 2021 May 11, 2021 | — | — | — | -$0.41 | -$0.41 | +0.00% | — | — |